These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10360744)

  • 41. Potential virtual lead identification in the discovery of renin inhibitors: application of ligand and structure-based pharmacophore modeling approaches.
    Thangapandian S; John S; Sakkiah S; Lee KW
    Eur J Med Chem; 2011 Jun; 46(6):2469-76. PubMed ID: 21497958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of accurate binding affinity predictions of novel renin inhibitors through molecular docking studies.
    Politi A; Durdagi S; Moutevelis-Minakakis P; Kokotos G; Mavromoustakos T
    J Mol Graph Model; 2010 Nov; 29(3):425-35. PubMed ID: 20855222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors.
    Bezençon O; Bur D; Weller T; Richard-Bildstein S; Remen L; Sifferlen T; Corminboeuf O; Grisostomi C; Boss C; Prade L; Delahaye S; Treiber A; Strickner P; Binkert C; Hess P; Steiner B; Fischli W
    J Med Chem; 2009 Jun; 52(12):3689-702. PubMed ID: 19358611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach.
    Berkhout TA; Blaney FE; Bridges AM; Cooper DG; Forbes IT; Gribble AD; Groot PH; Hardy A; Ife RJ; Kaur R; Moores KE; Shillito H; Willetts J; Witherington J
    J Med Chem; 2003 Sep; 46(19):4070-86. PubMed ID: 12954060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 2. Spiro-joined benzofuran, isobenzofuran, and benzopyran piperidines.
    Moltzen EK; Perregaard J; Meier E
    J Med Chem; 1995 May; 38(11):2009-17. PubMed ID: 7783132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Substituted dipiperidine alcohols as potent CCR2 antagonists.
    Xia M; Hou C; Demong D; Pollack S; Pan M; Brackley J; Singer M; Matheis M; Cavender D; Wachter M
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3562-4. PubMed ID: 18487045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis, stereochemistry, and biological activity of the 1-(1-phenyl-2-methylcyclohexyl)piperidines and the 1-(1-phenyl-4-methylcyclohexyl)piperidines. Absolute configuration of the potent trans-(-)-1-(1-phenyl-2-methylcyclohexyl)piperidine.
    Iorio MA; Tomassini L; Mattson MV; George C; Jacobson AE
    J Med Chem; 1991 Aug; 34(8):2615-23. PubMed ID: 1875352
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and dipeptidyl peptidase inhibition of N-(4-substituted-2,4-diaminobutanoyl)piperidines.
    Soroka A; Van der Veken P; De Meester I; Lambeir AM; Maes MB; Scharpé S; Haemers A; Augustyns K
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4777-9. PubMed ID: 16844373
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of a new biaryl scaffold generating potent renin inhibitors.
    Lacombe P; Aspiotis R; Bayly C; Chen A; Dubé D; Fortin R; Gallant M; Juteau H; Liu S; McKay D; Roy P; Wu T
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5822-6. PubMed ID: 20728350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enantioselective synthesis and antioxidant activity of 3,4,5-substituted piperidine derivatives.
    Kim JH; Shyam PK; Kim MJ; Lee HJ; Lee JT; Jang HY
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3119-3121. PubMed ID: 27177825
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.
    Burns DM; He C; Li Y; Scherle P; Liu X; Marando CA; Covington MB; Yang G; Pan M; Turner S; Fridman JS; Hollis G; Vaddi K; Yeleswaram S; Newton R; Friedman S; Metcalf B; Yao W
    Bioorg Med Chem Lett; 2008 Jan; 18(2):560-4. PubMed ID: 18068976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Piperidine amides as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors.
    Flyrén K; Bergquist LO; Castro VM; Fotsch C; Johansson L; St Jean DJ; Sutin L; Williams M
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3421-5. PubMed ID: 17442567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase.
    Butler CR; Beck EM; Harris A; Huang Z; McAllister LA; Am Ende CW; Fennell K; Foley TL; Fonseca K; Hawrylik SJ; Johnson DS; Knafels JD; Mente S; Noell GS; Pandit J; Phillips TB; Piro JR; Rogers BN; Samad TA; Wang J; Wan S; Brodney MA
    J Med Chem; 2017 Dec; 60(23):9860-9873. PubMed ID: 29148769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analyses of ligand binding in five endothiapepsin crystal complexes and their use in the design and evaluation of novel renin inhibitors.
    Lunney EA; Hamilton HW; Hodges JC; Kaltenbronn JS; Repine JT; Badasso M; Cooper JB; Dealwis C; Wallace BA; Lowther WT
    J Med Chem; 1993 Nov; 36(24):3809-20. PubMed ID: 8254610
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of novel human renin inhibitors through a combined approach of pharmacophore modelling, molecular DFT analysis and in silico screening.
    Gogoi D; Baruah VJ; Chaliha AK; Kakoti BB; Sarma D; Buragohain AK
    Comput Biol Chem; 2017 Aug; 69():28-40. PubMed ID: 28552695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design and optimization of a substituted amino propanamide series of renin inhibitors for the treatment of hypertension.
    Chen A; Bayly C; Bezençon O; Richard-Bildstein S; Dubé D; Dubé L; Gagné S; Gallant M; Gaudreault M; Grimm E; Houle R; Lacombe P; Laliberté S; Lévesque JF; Liu S; MacDonald D; Mackay B; Martin D; McKay D; Powell D; Remen L; Soisson S; Toulmond S
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2204-9. PubMed ID: 20206513
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Synthesis and antidepressant activities of aryl alkanol piperidine derivatives].
    Zheng YY; Gao K; Weng ZJ; Li JQ
    Yao Xue Xue Bao; 2010 Mar; 45(3):324-9. PubMed ID: 21351508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of (phenoxy-2-hydroxypropyl)piperidines as a novel class of voltage-gated sodium channel 1.7 inhibitors.
    Suzuki S; Kuroda T; Kimoto H; Domon Y; Kubota K; Kitano Y; Yokoyama T; Shimizugawa A; Sugita R; Koishi R; Asano D; Tamaki K; Shinozuka T; Kobayashi H
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5419-23. PubMed ID: 26358159
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A nonpeptide, piperidine renin inhibitor provides renal and cardiac protection in double-transgenic mice expressing human renin and angiotensinogen genes.
    Major TC; Olszewski B; Rosebury W; Okerberg C; Carlson T; Ostroski R; Schroeder R; Kowala MC; Leadley R
    Cardiovasc Drugs Ther; 2008 Dec; 22(6):469-78. PubMed ID: 18679781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure-activity relationship study of 4-substituted piperidines at Leu26 moiety of novel p53-hDM2 inhibitors.
    Tian Y; Ma Y; Gibeau CR; Lahue BR; Shipps GW; Strickland C; Bogen SL
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2735-8. PubMed ID: 27080185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.